abstract |
The present invention relates to compounds of the general formula (l): in which R1a, R1b and R4 are H, alkyl, etc.; R6 is H, halo etc; A is an ester group and B is a heterocyclic moiety, processes for their preparation and their use for the production of pharmaceutical compositions for the treatment of diseases and indications that are connected with the receptor EP4. |